Core Viewpoint - Ark Health Holdings Limited announced the resignation of Mr. Xie Fangmin as Chairman, CEO, and other positions effective December 7, 2025, to focus on personal matters, while he will continue to provide guidance as a non-executive director [1][2] Group 1: Leadership Changes - Mr. Xie Fangmin's resignation is respected by the board, which appreciates his significant contributions during his tenure [1] - David McKee Hand has been appointed as the new Chairman effective December 7, 2025, while the board will search for a new CEO from both internal and external candidates [1] Group 2: Company Strategy and Future Direction - Since its establishment in 2015, Mr. Xie has focused on the long-term development of the company, introducing the "H2H (Hospital to Home)" model and integrating AI with healthcare [2] - The company has transitioned from a pharmaceutical e-commerce platform to a leading "AI + chronic disease management" enterprise, successfully listing on the Hong Kong Stock Exchange in 2024 [2] - The company aims to continue focusing on online chronic disease management and building a win-win ecosystem for chronic disease services, contributing to the "Healthy China 2030" goal [2]
方舟云康(06086)发布公告：David McKee HAND获委任为主席 “AI+慢病管理”战略笃定前行